A Multicenter, Open Label Phase I Clinical Trial Evaluating the Safety and Pharmacokinetics of TQB2252 Injection in Subjects With Advanced Malignant Tumors

NCT06649656 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancers

Interventions

DRUG: TQB2252 injection

Sponsor

Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.